Discovery in Our Labs
The Winthrop P. Rockefeller Cancer Institute directs cancer research for the University of Arkansas for Medical Sciences (UAMS) and its affiliated institutions. Cancer Institute scientists are committed to reducing cancer incidence, mortality and morbidity in Arkansas and the surrounding region.
The Cancer Institute accomplishes its goals through focused research programs, shared resources and multidisciplinary disease-specific committees.
The Cancer Institute’s approach is simple: Discovery in our labs leads to the development of new treatment strategies, which are then delivered to the patients in our clinics. The bottom line for our patients is that our research fuels innovative treatment options.Our Research
Research Programs
All research at the Cancer Institute is organized into four distinct research programs to maximize and nurture scientific collaborations and productivity.
Learn More
Clinical Research
Clinical research conducted at the Cancer Institute focuses on cancer prevention, screening, treatment and support.
Learn More
Shared Resources
Shared resources provide Cancer Institute members with cost-effective access to specialized technologies, methodologies and quality control.
Learn More
Education
Numerous educational and training opportunities are available for cancer researchers from the Cancer Institute, the Translational Research Institute and UAMS Research Administrati
Learn More
Internal Funding
Internal funds available to support cancer research are updated monthly.
Learn More
Membership
The mission of the Winthrop P. Rockefeller Cancer Institute is to translate today’s discoveries into tomorrow’s strategies to effectively reduce cancer throughout its continuum fr
Learn MoreResearch: UAMS Researcher Delgado-Calle Awarded $1.7 Million to Study Bone Health in Myeloma Patients
LITTLE ROCK —Jesus Delgado-Calle, Ph.D., an assistant professor at the University of Arkansas for Medical Sciences (UAMS), has been awarded a National Cancer Institute grant of more than $1.7 million to study ways bone therapy might repair damaged bone and prevent or delay relapse in myeloma patients. Multiple myeloma, a cancer of the plasma cells…
More News
$1.9 Million Grant Funds DNA Damage Research by UAMS Scientist Justin Leung, Ph.D.
A $1.9 million grant from the National Institute of General Medical Studies (NIGMS) will allow a scientist at the University of Arkansas for Medical Sciences (UAMS) to advance his research of DNA damage response (DDR) in cancer and genetic disorders.
Read more
UAMS Researchers Awarded $11.4 Million Grant to Continue Study of Cancer Therapy Side Effects
LITTLE ROCK — Led by Marjan Boerma, Ph.D., a team of University of Arkansas for Medical Sciences (UAMS) researchers has received a five-year $11.4 million grant to continue research into the side effects of cancer therapies, including radiation and chemotherapies. The Centers for Biomedical Research Excellence (COBRE), a program of the National Institute of General…
Read more
UAMS Lung Cancer Researcher Contributes to Publication of Validation Protocols for Liquid Biopsy to Detect Cancer
Donald J. Johann, M.D., a lung cancer researcher at the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS), played an integral role in the publication of research related to liquid biopsy tests, or blood tests, for cancer.
Read more
UAMS’ Alan Tackett, Ph.D., Named to NIH Mechanisms of Cancer Therapeutics Study Section
Alan Tackett, Ph.D., was recently named a member of the National Institutes of Health (NIH) Mechanisms of Cancer Therapeutics-1 (MCT1) Study Section, one of the major review boards for evaluation of cancer research by the NIH Center for Scientific Review.
Read moreWant to read more stories like these?